Spermosens
Business Services · Sweden · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Medicon Village Scheeletorget 1, Lund, S...Phone Number
+46 103300442Website
www.spermosens.comRevenue
$5.7 MillionIndustry
About Spermosens
Is Spermosens your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Spermosens recently announced quarterly report
Check if Spermosens has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Spermosens has new funding data
Check out if Spermosens is spiking on competitors!
Click to see if Spermosens had a recent Job posting/layoffs
Product Launch: Get notified when Spermosens launches new products
Congratulate Masked Content for being promoted to Masked Content at Spermosens
Spermosens, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Spermosens
Find 2 more new buyers
Company Profile Activity
Activity Insights
Spermosens is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Spermosens is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Spermosens.
Spermosens Tech Stack
A closer look at the technologies used by Spermosens
Spermosens News & Media
Spermosens provides update on clinical progress, partner discussions and financing
Spermosens AB ("Spermosens" or the "Company") provides an update on its ongoing clinical study,Spermosens appoints Dr. Jaime Castillo-León as chief technology officer to drive innovation ...
Spermosens AB (publ) (“Spermosens” or the “Company”) is pleased to announce the appointment of Dr.Spermosens year-end status update: Strong progress and promising outlook for 2025
Spermosens AB (“Spermosens” or the “Company”) provides a year-end update on its progress in 2024, aSpermosens publishes outcome in rights issue
NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES OF AMERICA, AUSTRALIA, BELARUS, CANADA, HONG KONG, JAPAN, NEW ZEALAND, RUSSIA, SINGAPORE, SOUTH AFRICA, SOUTH KOREA, SWITZERLAND OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE On 3 October 2024, Spermosens AB (publ) (“Spermosens” or the “Company”) announced a rights issue of units of approximately SEK 22.7
Top Business Services Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Spermosens
Spermosens AB is a leading developer of male-factor infertility diagnostics, focusing on innovative technology to diagnose male infertility and guide appropriate treatment options. Their flagship product, the JUNO- diagnostic system, is designed to assess the fertilization capacity of sperm, enabling clinicians to make informed decisions regarding... Read More